Top-News

Neuralstem News

Keine aktuellen Kursdaten verfügbar
WKN: A2DJ8M
ISIN: US64127R4011
Typ: Aktie

Neuralstem News

25.10.21 - PR Newswire
Uranium, Strategic and Precious Metals Investor Presentations Now Available for On-Demand Viewing
Uranium, Strategic and Precious Metals Investor Presentations Now Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on ...
02.09.20 - PR Newswire
Letter from Seneca Biopharma's Executive Chairman
Letter from Seneca Biopharma's Executive Chairman PR Newswire
27.05.20 - PR Newswire
Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering
Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering PR Newswire
31.10.19 - PR Newswire
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA PR Newswire
28.10.19 - PR Newswire
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit PR Newswire
24.09.19 - PR Newswire
Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients
Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients PR Newswire
14.08.19 - PR Newswire
Neuralstem Reports Second Quarter 2019 Fiscal Results
Neuralstem Reports Second Quarter 2019 Fiscal Results PR Newswire
07.08.19 - PR Newswire
Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued Listing
Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued Listing PR Newswire
31.07.19 - PR Newswire
Neuralstem Closes $7.5 Million Underwritten Public Offering
Neuralstem Closes $7.5 Million Underwritten Public Offering PR Newswire
25.07.19 - PR Newswire
Neuralstem Announces Pricing of $7.5 Million Underwritten Public Offering
Neuralstem Announces Pricing of $7.5 Million Underwritten Public Offering PR Newswire
18.07.19 - PR Newswire
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors PR Newswire
16.07.19 - PR Newswire
Neuralstem Announces a 1-for-20 Reverse Stock Split
Neuralstem Announces a 1-for-20 Reverse Stock Split PR Newswire
01.07.19 - PR Newswire
Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients
Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients PR Newswire
14.05.19 - PR Newswire
Neuralstem Reports First Quarter 2019 Fiscal Results
Neuralstem Reports First Quarter 2019 Fiscal Results - Kenneth C. Carter, PhD appointed Executive Chairman - Strategic initiative to expand pipeline announced PR Newswire
06.05.19 - PR Newswire
Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors
Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors PR Newswire
07.02.19 - PR Newswire
Neuralstem to Expand Pipeline as Part of Aggressive Growth Effort
Neuralstem to Expand Pipeline as Part of Aggressive Growth Effort Neuralstem Engages Strategic Advisors to Evaluate Dozens of New Technologies PR Newswire
20.05.16 - PR Newswire
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent PR Newswire
12.05.16 - PR Newswire
Neuralstem to Raise $1.08 Million
Neuralstem to Raise $1.08 Million PR Newswire
12.05.16 - PR Newswire
Neuralstem Announces First Patient Enrolled in Phase 2 Clinical Trial in Major Depressive Disorder
Neuralstem Announces First Patient Enrolled in Phase 2 Clinical Trial in Major Depressive Disorder Trial Efficacy Endpoints Include Reduction in Depression and Cognition ...
09.05.16 - PR Newswire
Neuralstem Reports Fiscal First Quarter 2016 Results and Business Update
Neuralstem Reports Fiscal First Quarter 2016 Results and Business Update PR Newswire

Newssuche

Videos

newspaper
18.04.24
Technical Trading: Gold mit weiterem Potenzial
Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »